TGFB1 and inflammatory bowel disease: For example, in a study conducted on patients with inflammatory bowel disease (IBD), the MALAT-1 and miR-142-3p axis were found to be effective in increasing inflammation by reducing the level of Transforming growth factor beta (TGF-β) (110).